The Opioid Epidemic and Substance Use Disorders

Core Concepts

Tolerance, physical dependence, and substance use disorder — not the same thing

Tolerance means needing more of a drug to get the same effect — a normal pharmacological adaptation that develops with regular opioid use. Physical dependence means the body adapts so that stopping the drug abruptly causes withdrawal — also expected with sustained use and distinct from addiction. Substance use disorder is the behavioral syndrome: loss of control over use, cravings, continued use despite harm, and neglecting other life areas. Many people take opioids for legitimate pain, develop tolerance and dependence, and never have SUD; conversely, SUD can exist with little physical dependence. Conflating these three ideas is a common clinical and exam error, and it drives stigma when dependence is treated as addiction.

The three waves of the epidemic

The wave model explains how the epidemic's character changed over time. Wave one: aggressive promotion and expanded prescribing of prescription opioids for chronic non-cancer pain led to widespread exposure, diversion, and a rise in prescription-opioid overdose deaths. Wave two: as prescribing tightened and pills became harder to obtain, many people transitioned to heroin, which was cheaper and more available, and heroin-involved deaths rose. Wave three: illicit fentanyl and fentanyl analogs — up to many times more potent than morphine or heroin — entered the drug supply, often pressed into counterfeit pills or mixed with other drugs, driving a sharp rise in overdose deaths. Understanding the waves matters because each has different prevention levers: prescribing policy, treatment access, and drug-supply and harm-reduction responses respectively.

How opioids kill: respiratory depression

Opioids slow the brain's respiratory drive. In overdose, breathing becomes shallow and slow until it stops; brain injury and death follow within minutes if not reversed. Risk increases with high doses, mixing opioids with other central nervous system depressants (alcohol, benzodiazepines, sedatives), and resuming use after a period of abstinence, when tolerance has fallen — a common cause of death after release from jail or treatment. Naloxone is an opioid antagonist that rapidly reverses respiratory depression and is a cornerstone of community overdose response; education and distribution programs put it in the hands of people who use drugs, their families, and first responders. (Doses, formulations, and distribution rules vary by jurisdiction and should be learned from current local guidance.)

Medications for opioid use disorder (MOUD)

Opioid use disorder is a chronic, relapsing condition with effective medical treatment. Medications for opioid use disorder — methadone (dispensed through regulated opioid treatment programs), buprenorphine (which can be prescribed in office settings in many jurisdictions), and naltrexone (which blocks opioid effects) — reduce cravings, withdrawal, and overdose deaths, and are most effective when combined with counseling and social support. Despite strong evidence, treatment capacity is far below need, and stigma, cost, and regulatory barriers limit access. Nurses support MOUD by assessing, educating, reducing stigma, monitoring, and connecting people to prescribers — and, in advanced practice roles, by prescribing within their scope. Medication names, dosing, and access rules change and vary; the educational point is that medication treatment works and is underused.

Harm reduction and the nursing role

Harm reduction is a public-health approach that aims to reduce the harms of drug use without requiring abstinence first — meeting people where they are. Examples include naloxone distribution, syringe services programs (which reduce HIV and hepatitis C transmission and link people to care), fentanyl test strips, and safe-consumption messaging. Harm reduction is evidence-based and cost-effective, yet politically contested; nurses should understand the evidence and the controversy, and follow institutional policy. The nursing role across the epidemic: screen (e.g., brief screening questions and tools used in many settings), educate on overdose risk and response, treat people who use drugs with dignity, connect them to treatment and social services, and advocate for accessible, non-stigmatizing care. Person-first language ("person who uses drugs," "person with opioid use disorder") is standard and reduces the discrimination that keeps people out of care.

Common Confusions